TrialCardiovascular diabetology2021

A prospective randomized study comparing effects of empagliflozin to sitagliptin on cardiac fat accumulation, cardiac function, and cardiac metabolism in patients with early-stage type 2 diabetes: the ASSET study.

Shigenori Hiruma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.